Global and United States Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2020-2026

Global and United States Biopharmaceutical Contract Manufacturing Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Growth Factors
1.2.3 Interferons
1.2.4 Monoclonal Antibodies
1.2.5 Recombinant Hormones
1.2.6 Vaccines
1.2.7 Insulin
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
1.3.2 Autoimmune Diseases
1.3.3 Oncology
1.3.4 Metabolic Diseases
1.3.5 Ophthalmology
1.3.6 Cardiovascular Diseases
1.3.7 Infectious Diseases
1.3.8 Neurology
1.3.9 Respiratory Disorders
1.3.10 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biopharmaceutical Contract Manufacturing Market Perspective (2015-2026)
2.2 Global Biopharmaceutical Contract Manufacturing Growth Trends by Regions
2.2.1 Biopharmaceutical Contract Manufacturing Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biopharmaceutical Contract Manufacturing Historic Market Share by Regions (2015-2020)
2.2.3 Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biopharmaceutical Contract Manufacturing Players by Market Size
3.1.1 Global Top Biopharmaceutical Contract Manufacturing Players by Revenue (2015-2020)
3.1.2 Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Players (2015-2020)
3.2 Global Biopharmaceutical Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biopharmaceutical Contract Manufacturing Revenue
3.4 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio
3.4.1 Global Biopharmaceutical Contract Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biopharmaceutical Contract Manufacturing Revenue in 2019
3.5 Key Players Biopharmaceutical Contract Manufacturing Area Served
3.6 Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
3.7 Date of Enter into Biopharmaceutical Contract Manufacturing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biopharmaceutical Contract Manufacturing Breakdown Data by Type (2015-2026)
4.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Type (2015-2020)
4.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Type (2021-2026)
5 Biopharmaceutical Contract Manufacturing Breakdown Data by Application (2015-2026)
5.1 Global Biopharmaceutical Contract Manufacturing Historic Market Size by Application (2015-2020)
5.2 Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biopharmaceutical Contract Manufacturing Market Size (2015-2026)
6.2 North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
6.3 North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
6.4 North America Biopharmaceutical Contract Manufacturing Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Biopharmaceutical Contract Manufacturing Market Size (2015-2026)
7.2 Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
7.3 Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
7.4 Europe Biopharmaceutical Contract Manufacturing Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Biopharmaceutical Contract Manufacturing Market Size (2015-2026)
8.2 China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
8.3 China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
8.4 China Biopharmaceutical Contract Manufacturing Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Biopharmaceutical Contract Manufacturing Market Size (2015-2026)
9.2 Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
9.3 Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
9.4 Japan Biopharmaceutical Contract Manufacturing Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size (2015-2026)
10.2 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020)
10.3 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020)
10.4 Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Lonza Group
11.1.1 Lonza Group Company Details
11.1.2 Lonza Group Business Overview
11.1.3 Lonza Group Biopharmaceutical Contract Manufacturing Introduction
11.1.4 Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020))
11.1.5 Lonza Group Recent Development
11.2 Baxter Biopharma Solutions
11.2.1 Baxter Biopharma Solutions Company Details
11.2.2 Baxter Biopharma Solutions Business Overview
11.2.3 Baxter Biopharma Solutions Biopharmaceutical Contract Manufacturing Introduction
11.2.4 Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.2.5 Baxter Biopharma Solutions Recent Development
11.3 Samsung
11.3.1 Samsung Company Details
11.3.2 Samsung Business Overview
11.3.3 Samsung Biopharmaceutical Contract Manufacturing Introduction
11.3.4 Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.3.5 Samsung Recent Development
11.4 Fujifilm Diosynth Biotechnologies
11.4.1 Fujifilm Diosynth Biotechnologies Company Details
11.4.2 Fujifilm Diosynth Biotechnologies Business Overview
11.4.3 Fujifilm Diosynth Biotechnologies Biopharmaceutical Contract Manufacturing Introduction
11.4.4 Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.4.5 Fujifilm Diosynth Biotechnologies Recent Development
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Biopharmaceutical Contract Manufacturing Introduction
11.5.4 Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.5.5 Boehringer Ingelheim Recent Development
11.6 Patheon
11.6.1 Patheon Company Details
11.6.2 Patheon Business Overview
11.6.3 Patheon Biopharmaceutical Contract Manufacturing Introduction
11.6.4 Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.6.5 Patheon Recent Development
11.7 Rentschler Biotechnologie
11.7.1 Rentschler Biotechnologie Company Details
11.7.2 Rentschler Biotechnologie Business Overview
11.7.3 Rentschler Biotechnologie Biopharmaceutical Contract Manufacturing Introduction
11.7.4 Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.7.5 Rentschler Biotechnologie Recent Development
11.8 Biomeva
11.8.1 Biomeva Company Details
11.8.2 Biomeva Business Overview
11.8.3 Biomeva Biopharmaceutical Contract Manufacturing Introduction
11.8.4 Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.8.5 Biomeva Recent Development
11.9 Probiogen
11.9.1 Probiogen Company Details
11.9.2 Probiogen Business Overview
11.9.3 Probiogen Biopharmaceutical Contract Manufacturing Introduction
11.9.4 Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.9.5 Probiogen Recent Development
11.10 Cytovance Biologics
11.10.1 Cytovance Biologics Company Details
11.10.2 Cytovance Biologics Business Overview
11.10.3 Cytovance Biologics Biopharmaceutical Contract Manufacturing Introduction
11.10.4 Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
11.10.5 Cytovance Biologics Recent Development
11.11 KBI Biopharma
10.11.1 KBI Biopharma Company Details
10.11.2 KBI Biopharma Business Overview
10.11.3 KBI Biopharma Biopharmaceutical Contract Manufacturing Introduction
10.11.4 KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.11.5 KBI Biopharma Recent Development
11.12 WuXi Biologics
10.12.1 WuXi Biologics Company Details
10.12.2 WuXi Biologics Business Overview
10.12.3 WuXi Biologics Biopharmaceutical Contract Manufacturing Introduction
10.12.4 WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.12.5 WuXi Biologics Recent Development
11.13 Abzena
10.13.1 Abzena Company Details
10.13.2 Abzena Business Overview
10.13.3 Abzena Biopharmaceutical Contract Manufacturing Introduction
10.13.4 Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020)
10.13.5 Abzena Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biopharmaceutical Contract Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Growth Factors
Table 4. Key Players of Interferons
Table 5. Key Players of Monoclonal Antibodies
Table 6. Key Players of Recombinant Hormones
Table 7. Key Players of Vaccines
Table 8. Key Players of Insulin
Table 9. Key Players of Others
Table 10. Global Biopharmaceutical Contract Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Biopharmaceutical Contract Manufacturing Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2015-2020)
Table 14. Global Biopharmaceutical Contract Manufacturing Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2021-2026)
Table 16. Biopharmaceutical Contract Manufacturing Market Market Trends
Table 17. Biopharmaceutical Contract Manufacturing Market Drivers
Table 18. Biopharmaceutical Contract Manufacturing Market Challenges
Table 19. Biopharmaceutical Contract Manufacturing Market Restraints
Table 20. Global Biopharmaceutical Contract Manufacturing Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Biopharmaceutical Contract Manufacturing Market Share by Players (2015-2020)
Table 22. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2019)
Table 23. Global Biopharmaceutical Contract Manufacturing by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biopharmaceutical Contract Manufacturing Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Biopharmaceutical Contract Manufacturing Market Size Share by Type (2015-2020)
Table 29. Global Biopharmaceutical Contract Manufacturing Revenue Market Share by Type (2021-2026)
Table 30. Global Biopharmaceutical Contract Manufacturing Market Size Share by Application (2015-2020)
Table 31. Global Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Biopharmaceutical Contract Manufacturing Market Size Share by Application (2021-2026)
Table 33. North America Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 35. North America Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 37. North America Biopharmaceutical Contract Manufacturing Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Biopharmaceutical Contract Manufacturing Market Share by Country (2015-2020)
Table 39. Europe Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 41. Europe Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 43. Europe Biopharmaceutical Contract Manufacturing Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Biopharmaceutical Contract Manufacturing Market Share by Country (2015-2020)
Table 45. China Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 46. China Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 47. China Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 48. China Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 49. China Biopharmaceutical Contract Manufacturing Market Size by Region (US$ Million) (2015-2020)
Table 50. China Biopharmaceutical Contract Manufacturing Market Share by Region (2015-2020)
Table 51. Japan Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 53. Japan Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 55. Japan Biopharmaceutical Contract Manufacturing Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Biopharmaceutical Contract Manufacturing Market Share by Country (2015-2020)
Table 57. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Biopharmaceutical Contract Manufacturing Market Share by Type (2015-2020)
Table 59. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Biopharmaceutical Contract Manufacturing Market Share by Application (2015-2020)
Table 61. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Biopharmaceutical Contract Manufacturing Market Share by Country (2015-2020)
Table 63. Lonza Group Company Details
Table 64. Lonza Group Business Overview
Table 65. Lonza Group Product
Table 66. Lonza Group Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 67. Lonza Group Recent Development
Table 68. Baxter Biopharma Solutions Company Details
Table 69. Baxter Biopharma Solutions Business Overview
Table 70. Baxter Biopharma Solutions Product
Table 71. Baxter Biopharma Solutions Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 72. Baxter Biopharma Solutions Recent Development
Table 73. Samsung Company Details
Table 74. Samsung Business Overview
Table 75. Samsung Product
Table 76. Samsung Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 77. Samsung Recent Development
Table 78. Fujifilm Diosynth Biotechnologies Company Details
Table 79. Fujifilm Diosynth Biotechnologies Business Overview
Table 80. Fujifilm Diosynth Biotechnologies Product
Table 81. Fujifilm Diosynth Biotechnologies Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 82. Fujifilm Diosynth Biotechnologies Recent Development
Table 83. Boehringer Ingelheim Company Details
Table 84. Boehringer Ingelheim Business Overview
Table 85. Boehringer Ingelheim Product
Table 86. Boehringer Ingelheim Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 87. Boehringer Ingelheim Recent Development
Table 88. Patheon Company Details
Table 89. Patheon Business Overview
Table 90. Patheon Product
Table 91. Patheon Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 92. Patheon Recent Development
Table 93. Rentschler Biotechnologie Company Details
Table 94. Rentschler Biotechnologie Business Overview
Table 95. Rentschler Biotechnologie Product
Table 96. Rentschler Biotechnologie Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 97. Rentschler Biotechnologie Recent Development
Table 98. Biomeva Business Overview
Table 99. Biomeva Product
Table 100. Biomeva Company Details
Table 101. Biomeva Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 102. Biomeva Recent Development
Table 103. Probiogen Company Details
Table 104. Probiogen Business Overview
Table 105. Probiogen Product
Table 106. Probiogen Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 107. Probiogen Recent Development
Table 108. Cytovance Biologics Company Details
Table 109. Cytovance Biologics Business Overview
Table 110. Cytovance Biologics Product
Table 111. Cytovance Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 112. Cytovance Biologics Recent Development
Table 113. KBI Biopharma Company Details
Table 114. KBI Biopharma Business Overview
Table 115. KBI Biopharma Product
Table 116. KBI Biopharma Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 117. KBI Biopharma Recent Development
Table 118. WuXi Biologics Company Details
Table 119. WuXi Biologics Business Overview
Table 120. WuXi Biologics Product
Table 121. WuXi Biologics Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 122. WuXi Biologics Recent Development
Table 123. Abzena Company Details
Table 124. Abzena Business Overview
Table 125. Abzena Product
Table 126. Abzena Revenue in Biopharmaceutical Contract Manufacturing Business (2015-2020) (US$ Million)
Table 127. Abzena Recent Development
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biopharmaceutical Contract Manufacturing Market Share by Type: 2020 VS 2026
Figure 2. Growth Factors Features
Figure 3. Interferons Features
Figure 4. Monoclonal Antibodies Features
Figure 5. Recombinant Hormones Features
Figure 6. Vaccines Features
Figure 7. Insulin Features
Figure 8. Others Features
Figure 9. Global Biopharmaceutical Contract Manufacturing Market Share by Application: 2020 VS 2026
Figure 10. Autoimmune Diseases Case Studies
Figure 11. Oncology Case Studies
Figure 12. Metabolic Diseases Case Studies
Figure 13. Ophthalmology Case Studies
Figure 14. Cardiovascular Diseases Case Studies
Figure 15. Infectious Diseases Case Studies
Figure 16. Neurology Case Studies
Figure 17. Respiratory Disorders Case Studies
Figure 18. Others Case Studies
Figure 19. Biopharmaceutical Contract Manufacturing Report Years Considered
Figure 20. Global Biopharmaceutical Contract Manufacturing Market Size (US$ Million), YoY Growth 2015-2026
Figure 21. Global Biopharmaceutical Contract Manufacturing Market Share by Regions: 2020 VS 2026
Figure 22. Global Biopharmaceutical Contract Manufacturing Market Share by Regions (2021-2026)
Figure 23. Global Biopharmaceutical Contract Manufacturing Market Share by Players in 2019
Figure 24. Global Top Biopharmaceutical Contract Manufacturing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharmaceutical Contract Manufacturing as of 2019
Figure 25. The Top 10 and 5 Players Market Share by Biopharmaceutical Contract Manufacturing Revenue in 2019
Figure 26. North America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. United States Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. Canada Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Germany Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. France Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. U.K. Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Italy Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Russia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Nordic Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Rest of Europe Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. China Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Japan Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. South Korea Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Southeast Asia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. India Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Australia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Rest of Asia-Pacific Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Latin America Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Mexico Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. Brazil Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Turkey Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 50. Saudi Arabia Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 51. UAE Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 52. Rest of Middle East & Africa Biopharmaceutical Contract Manufacturing Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 53. Lonza Group Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 54. Baxter Biopharma Solutions Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 55. Samsung Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 56. Fujifilm Diosynth Biotechnologies Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 57. Boehringer Ingelheim Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 58. Patheon Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 59. Rentschler Biotechnologie Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 60. Biomeva Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 61. Probiogen Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 62. Cytovance Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 63. KBI Biopharma Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 64. WuXi Biologics Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 65. Abzena Revenue Growth Rate in Biopharmaceutical Contract Manufacturing Business (2015-2020)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs